We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+2.16%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+377.38%
AUM
$881M
AUM Growth
-$121M
Cap. Flow
-$139M
Cap. Flow %
-15.77%
Top 10 Hldgs %
39.5%
Holding
4,106
New
974
Increased
850
Reduced
839
Closed
1,374

Sector Composition

Rank Sector Weight
1 Technology 2.15%
2 Energy 2.14%
3 Industrials 2.11%
4 Financials 2.11%
5 Consumer Discretionary 1.95%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PHI icon
901
PLDT
PHI
$4.24B
$37K ﹤0.01%
1,059
+759
+253% +$26.8K
TXMD icon
902
TherapeuticsMD
TXMD
$24M
$37K ﹤0.01%
140
+130
+1,300% +$32.6K
SEI
903
Solaris Energy Infrastructure
SEI
$3.41B
$37K ﹤0.01%
+3,244
New +$36.8K
HEP
904
DELISTED
Holly Energy Partners, L.P.
HEP
$37K ﹤0.01%
+1,141
New +$38.8K
AUY
905
DELISTED
Yamana Gold, Inc.
AUY
$37K ﹤0.01%
11,856
+3,788
+47% +$10.2K
LPT
906
DELISTED
Liberty Property Trust
LPT
$37K ﹤0.01%
900
+121
+16% +$4.97K
PAY
907
DELISTED
Verifone Systems Inc
PAY
$37K ﹤0.01%
2,041
+1,254
+159% +$22.6K
AME icon
908
Ametek
AME
$58.4B
$36K ﹤0.01%
+604
New +$35.6K
ARCB icon
909
ArcBest
ARCB
$3.17B
$36K ﹤0.01%
1,732
+1,674
+2,886% +$36.3K
BCH icon
910
Banco de Chile
BCH
$21B
$36K ﹤0.01%
1,458
-818
-36% -$19.7K
CVEO icon
911
Civeo
CVEO
$358M
$36K ﹤0.01%
1,438
-293
-17% -$8.73K
HCA icon
912
HCA Healthcare
HCA
$88.7B
$36K ﹤0.01%
410
+309
+306% +$26.1K
IMUX icon
913
Immunic
IMUX
$191M
$36K ﹤0.01%
31
+12
+63% +$16K
LAUR icon
914
Laureate Education
LAUR
$5.24B
$36K ﹤0.01%
2,037
+171
+9% +$2.71K
LVS icon
915
Las Vegas Sands
LVS
$29.7B
$36K ﹤0.01%
560
-362
-39% -$21.7K
MGA icon
916
Magna International
MGA
$19.2B
$36K ﹤0.01%
600
-2,643
-81% -$115K
STN icon
917
Stantec
STN
$8.34B
$36K ﹤0.01%
1,091
-2,947
-73% -$72.4K
USPH icon
918
US Physical Therapy
USPH
$1.18B
$36K ﹤0.01%
+600
New +$38.3K
VLO icon
919
Valero Energy
VLO
$87.1B
$36K ﹤0.01%
538
+191
+55% +$12.4K
ECYT
920
DELISTED
Endocyte, Inc. Common Stock
ECYT
$36K ﹤0.01%
+23,841
New +$51.2K
ANDV
921
DELISTED
Andeavor
ANDV
$36K ﹤0.01%
385
+339
+737% +$28.6K
XCO
922
DELISTED
Exco Resources
XCO
$36K ﹤0.01%
+13,712
New +$81.1K
CHU
923
DELISTED
China Unicom (HONG KONG) Limited
CHU
$36K ﹤0.01%
2,424
-279
-10% -$3.88K
APH icon
924
Amphenol
APH
$212B
$35K ﹤0.01%
1,912
+1,296
+210% +$23.7K
CIX icon
925
Comp X International
CIX
$346M
$35K ﹤0.01%
2,330

Similar funds

Tower Research Capital (TRC)'s Q2 2017 Portfolio in Review

As of Q2 2017, Tower Research Capital (TRC) held 4,106 positions worth $881M, down 12% from $1B the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Tower Research Capital (TRC) withdrew a net $139M in Q2 2017, closing 1,374 positions and reducing 839 holdings. Its most notable exit was State Street SPDR S&P Retail ETF, an estimated $5.29M position sold in full.

By sector, the portfolio is most concentrated in Technology at 2.1% of assets, up from 1.5% a quarter earlier, followed by Energy and Industrials.

Against the trend, Tower Research Capital (TRC) opened a new position in State Street Consumer Discretionary Select Sector SPDR ETF worth $17.2M.

  • Tower Research Capital (TRC)'s largest Q2 2017 buy was State Street Consumer Discretionary Select Sector SPDR ETF: 382,942 shares worth $17.2M.
  • Tower Research Capital (TRC) added most to iShares MSCI Emerging Markets ETF in Q2 2017, an estimated $60M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2017 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $152M.
  • Tower Research Capital (TRC) fully exited State Street SPDR S&P Retail ETF in Q2 2017, selling an estimated $5.29M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 40% of its $881M portfolio in Q2 2017.
  • Tower Research Capital (TRC) opened 974 new positions and closed 1,374 in Q2 2017.
  • Tower Research Capital (TRC)'s portfolio value fell 12% quarter-over-quarter to $881M.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2017, filed 15 Aug 2017.